On the other hand, to address whether only 5-FU-resistant colorectal cancer cells show over-activation of AKT signaling, we compared SNU-C5/5-FU and SNU-C5/OXT, an oxaliplatin-resistant cell line. The gene discussed is AKT1; the disease is colorectal cancer.